{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27245225", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "06", "Day": "01"}], "ELocationID": ["159", "10.1186/s12906-016-1144-7"], "Language": ["eng"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2016", "Month": "Jun", "Day": "01"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice.", "Pagination": {"StartPage": "159", "MedlinePgn": "159"}, "Abstract": {"AbstractText": ["Synaptic dysfunction is one of the pathological characteristics of Alzheimer's disease (AD), which is directly related to the progressive decline of cognitive function. CaMKII and CaN have been found to play important roles in memory processes and synaptic transmission. So present study aimed to elucidate relationships between CaMKII, CaN and cognitive decline in APPV717I mice, and to reveal whether the cognitive improving effects of GAPT is conducted through rebalance CaMKII and CaN.", "Three-month-old-male APPV717I mice were randomly divided into ten groups (n\u2009=\u200912 per group) and received intragastrically administrated vehicle, donepezil or different doses of herbal formula GAPT for 8 or 4\u00a0months. Three-month-old male C57BL/6\u00a0J mice was set as vehicle control.", "Immunohistochemistry analysis showed that there were CaMKII expression decrease in the CA1 region of APPV717I transgenic mice, while the CaMKII expression of donepezil or GAPT treated transgenic mice were all increased. And there were CaN expression increase in the brain cortex of APPV717I transgenic mice, while there were decrease of CaN expression in donepezil or GAPT treated transgenic group. Western blot analysis showed the similar expression pattern without significant difference.", "GAPT extract have showed effectiveness in activating the expression of CaMKII and inhibiting the expression of CaN either before or after the formation of amyloid plaques in the brain of APPV717I transgenic mice, which may in certain way alleviated neuron synaptic dysfunction in AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Shi", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Zhang", "ForeName": "Xuekai", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Yin", "ForeName": "Long", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Wei", "ForeName": "Mingqing", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Ni", "ForeName": "Jingnian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China."}], "LastName": "Li", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Chinese Internal Medicine, Ministry of Education, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Wang", "ForeName": "Pengwen", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The 3rd Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. jztian@hotmail.com."}], "LastName": "Tian", "ForeName": "Jinzhou", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Wang", "ForeName": "Yongyan", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "EC 2.7.11.17", "NameOfSubstance": "Calcium-Calmodulin-Dependent Protein Kinase Type 2"}, {"RegistryNumber": "EC 3.1.3.16", "NameOfSubstance": "Calcineurin"}], "CommentsCorrectionsList": [{"RefSource": "BMC Complement Med Ther. 2021 May 28;21(1):157. doi: 10.1186/s12906-021-03331-0", "PMID": "34049557"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcineurin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium-Calmodulin-Dependent Protein Kinase Type 2"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137\u2013152. doi: 10.1038/nrneurol.2011.2.", "ArticleIdList": ["10.1038/nrneurol.2011.2", "PMC3339565", "21304480"]}, {"Citation": "Davies CA, Mann DMA, Sumpter PQ, Yates PO. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci. 1987;78(2):151\u2013164. doi: 10.1016/0022-510X(87)90057-8.", "ArticleIdList": ["10.1016/0022-510X(87)90057-8", "3572454"]}, {"Citation": "Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm. 1996;103(5):603\u2013618. doi: 10.1007/BF01273157.", "ArticleIdList": ["10.1007/BF01273157", "8811505"]}, {"Citation": "Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62(6):925\u2013931. doi: 10.1212/01.WNL.0000115115.98960.37.", "ArticleIdList": ["10.1212/01.WNL.0000115115.98960.37", "15037694"]}, {"Citation": "Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361(6407):31\u201339. doi: 10.1038/361031a0.", "ArticleIdList": ["10.1038/361031a0", "8421494"]}, {"Citation": "Kennedy MB. Regulation of synaptic transmission in the central nervous system: Long-term potentiation. Cell. 1989;59(5):777\u2013787. doi: 10.1016/0092-8674(89)90601-6.", "ArticleIdList": ["10.1016/0092-8674(89)90601-6", "2556217"]}, {"Citation": "Nicoll RA, Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature. 1995;377(6545):115\u2013118. doi: 10.1038/377115a0.", "ArticleIdList": ["10.1038/377115a0", "7675078"]}, {"Citation": "Stevens CF. A million dollar question: Does LTP\u2009=\u2009Memory? Neuron. 1998;20(1):1\u20132. doi: 10.1016/S0896-6273(00)80426-2.", "ArticleIdList": ["10.1016/S0896-6273(00)80426-2", "9459434"]}, {"Citation": "Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci. 2002;3(3):175\u2013190. doi: 10.1038/nrn753.", "ArticleIdList": ["10.1038/nrn753", "11994750"]}, {"Citation": "Silva A, Stevens C, Tonegawa S, Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science. 1992;257(5067):201\u2013206. doi: 10.1126/science.1378648.", "ArticleIdList": ["10.1126/science.1378648", "1378648"]}, {"Citation": "Soderling TR. Calcium/calmodulin-dependent protein kinase II: role in learning and memory. Mol Cell Biochem. 1993;127(1):93\u2013101. doi: 10.1007/BF01076760.", "ArticleIdList": ["10.1007/BF01076760", "7935366"]}, {"Citation": "Griffith LC. Calcium/Calmodulin-dependent protein Kinase II: an unforgettable Kinase. J Neurosci. 2004;24(39):8391\u20138393. doi: 10.1523/JNEUROSCI.2888-04.2004.", "ArticleIdList": ["10.1523/JNEUROSCI.2888-04.2004", "PMC6729888", "15456809"]}, {"Citation": "Stevens CF, Tonegawa S, Wang Y. The role of calcium calmodulin kinase II in three forms of synaptic plasticity. Curr Biol. 1994;4(8):687\u2013693. doi: 10.1016/S0960-9822(00)00153-6.", "ArticleIdList": ["10.1016/S0960-9822(00)00153-6", "7953554"]}, {"Citation": "Mansuy IM. Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun. 2003;311(4):1195\u20131208. doi: 10.1016/j.bbrc.2003.10.046.", "ArticleIdList": ["10.1016/j.bbrc.2003.10.046", "14623305"]}, {"Citation": "Hara MR, Snyder SH. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol. 2007;47(1):117\u2013141. doi: 10.1146/annurev.pharmtox.47.120505.105311.", "ArticleIdList": ["10.1146/annurev.pharmtox.47.120505.105311", "16879082"]}, {"Citation": "Kennedy MB, Bennett MK, Bulleit RF, Erondu NE, Jennings VR, Miller SG, Molloy SS, Patton BL, Schenker LJ. Structure and regulation of type II calcium/calmodulin-dependent protein kinase in central nervous system neurons. Cold Spring Harb Symp Quant Biol. 1990;55:101\u2013110. doi: 10.1101/SQB.1990.055.01.013.", "ArticleIdList": ["10.1101/SQB.1990.055.01.013", "1966761"]}, {"Citation": "Anderson M, Braun A, Schulman H, Premack B. Multifunctional Ca2+/calmodulin-dependent protein kinase mediates Ca(2+)-induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes. Circ Res. 1994;75(5):854\u2013861. doi: 10.1161/01.RES.75.5.854.", "ArticleIdList": ["10.1161/01.RES.75.5.854", "7923631"]}, {"Citation": "Neal Waxham M, Malenka RC, Kelly PT, Mauk MD. Calcium/calmodulin-dependent protein kinase II regulates hippocampal synaptic transmission. Brain Res. 1993;609(1\u20132):1\u20138. doi: 10.1016/0006-8993(93)90847-G.", "ArticleIdList": ["10.1016/0006-8993(93)90847-G", "8389645"]}, {"Citation": "Ouimet CC, McGuinness TL, Greengard P. Immunocytochemical localization of calcium/calmodulin-dependent protein kinase II in rat brain. Proc Natl Acad Sci U S A. 1984;81(17):5604\u20135608. doi: 10.1073/pnas.81.17.5604.", "ArticleIdList": ["10.1073/pnas.81.17.5604", "PMC391755", "6591208"]}, {"Citation": "Erondu NE, Kennedy MB. Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain. J Neurosci. 1985;5(12):3270\u20133277.", "ArticleIdList": ["PMC6565219", "4078628"]}, {"Citation": "Fukunaga K, Goto S, Miyamoto E. Immunohistochemical localization of Ca2+/Calmodulin-dependent protein Kinase II in Rat brain and various tissues. J Neurochem. 1988;51(4):1070\u20131078. doi: 10.1111/j.1471-4159.1988.tb03070.x.", "ArticleIdList": ["10.1111/j.1471-4159.1988.tb03070.x", "3047316"]}, {"Citation": "Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, Sheng M. Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem. 2004;279(20):21003\u201321011. doi: 10.1074/jbc.M400103200.", "ArticleIdList": ["10.1074/jbc.M400103200", "15020595"]}, {"Citation": "Rich DP, Cdlbran RJ, Schworer CM, Soderling TR. Regulatory properties of calcium/calmodulin-dependent protein Kinase II in rat brain postsynaptic densities. J Neurochem. 1989;53(3):807\u2013816. doi: 10.1111/j.1471-4159.1989.tb11777.x.", "ArticleIdList": ["10.1111/j.1471-4159.1989.tb11777.x", "2547902"]}, {"Citation": "Fukunaga K, Stoppini L, Miyamoto E, Muller D. Long-term potentiation is associated with an increased activity of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem. 1993;268(11):7863\u20137867.", "ArticleIdList": ["8385124"]}, {"Citation": "Ito I, Hidaka H, Sugiyama H. Effects of KN-62, a specific inhibitor of calcium/calmodulin-dependent protein kinase II, on long-term potentiation in the rat hippocampus. Neurosci Lett. 1991;121(1\u20132):119\u201321.", "ArticleIdList": ["1850502"]}, {"Citation": "Malinow R, Schulman H, Tsien R. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science. 1989;245(4920):862\u2013866. doi: 10.1126/science.2549638.", "ArticleIdList": ["10.1126/science.2549638", "2549638"]}, {"Citation": "Silva A, Paylor R, Wehner J, Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science. 1992;257(5067):206\u2013211. doi: 10.1126/science.1321493.", "ArticleIdList": ["10.1126/science.1321493", "1321493"]}, {"Citation": "Shirke AM, Malinow R. Mechanisms of potentiation by calcium-calmodulin kinase ii of postsynaptic sensitivity in rat hippocampal CA1 Neurons. J Neurophysiol. 1997;78(5):2682\u20132692.", "ArticleIdList": ["9356418"]}, {"Citation": "Lledo PM, Hjelmstad GO, Mukherji S, Soderling TR, Malenka RC, Nicoll RA. Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc Natl Acad Sci. 1995;92(24):11175\u201311179. doi: 10.1073/pnas.92.24.11175.", "ArticleIdList": ["10.1073/pnas.92.24.11175", "PMC40594", "7479960"]}, {"Citation": "Poncer JC, Esteban JA, Malinow R. Multiple Mechanisms for the potentiation of AMPA receptor-mediated transmission by \u03b1-ca2+/calmodulin-dependent protein kinase II. J Neurosci. 2002;22(11):4406\u20134411.", "ArticleIdList": ["PMC6758819", "12040047"]}, {"Citation": "Matsui H, Itano T, Etoh S, Tokuda M, Wang JH, Hatase O. Demonstration of different regional distributions of calcineurin subunits using monoclonal antibodies. Adv Exp Med Biol. 1989;255:369\u2013375. doi: 10.1007/978-1-4684-5679-0_40.", "ArticleIdList": ["10.1007/978-1-4684-5679-0_40", "2559600"]}, {"Citation": "Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A. Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci. 2001;21(11):4066\u20134073.", "ArticleIdList": ["PMC1201477", "11356894"]}, {"Citation": "Dineley KT, Hogan D, Zhang W-R, Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem. 2007;88(2):217\u2013224. doi: 10.1016/j.nlm.2007.03.010.", "ArticleIdList": ["10.1016/j.nlm.2007.03.010", "PMC2031869", "17521929"]}, {"Citation": "Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, Miyakawa T, Bear MF, Tonegawa S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell. 2001;107(5):617\u2013629. doi: 10.1016/S0092-8674(01)00585-2.", "ArticleIdList": ["10.1016/S0092-8674(01)00585-2", "11733061"]}, {"Citation": "Taglialatela G, Hogan D, Zhang W-R, Dineley KT. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res. 2009;200(1):95\u201399. doi: 10.1016/j.bbr.2008.12.034.", "ArticleIdList": ["10.1016/j.bbr.2008.12.034", "PMC2663011", "19162087"]}, {"Citation": "Malleret G, Haditsch U, Genoux D, Jones MW, Bliss TVP, Vanhoose AM, Weitlauf C, Kandel ER, Winder DG, Mansuy IM. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell. 2001;104(5):675\u2013686. doi: 10.1016/S0092-8674(01)00264-1.", "ArticleIdList": ["10.1016/S0092-8674(01)00264-1", "11257222"]}, {"Citation": "Lian Q, Ladner CJ, Magnuson D, Lee JM. Selective changes of calcineurin (protein phosphatase 2b) activity in Alzheimer's disease cerebral cortex. Exp Neurol. 2001;167(1):158\u2013165. doi: 10.1006/exnr.2000.7534.", "ArticleIdList": ["10.1006/exnr.2000.7534", "11161603"]}, {"Citation": "Ladner CJ, Czech J, Maurice J, Lorens SA, Lee JM. Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J Neuropathol Exp Neurol. 1996;55(8):924\u2013931. doi: 10.1097/00005072-199608000-00008.", "ArticleIdList": ["10.1097/00005072-199608000-00008", "8759782"]}, {"Citation": "Celsi F, Svedberg M, Unger C, Cotman CW, Carr\u00ec MT, Ottersen OP, Nordberg A, Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis. 2007;26(2):342\u2013352. doi: 10.1016/j.nbd.2006.12.022.", "ArticleIdList": ["10.1016/j.nbd.2006.12.022", "17344052"]}, {"Citation": "Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, Gong CX. Truncation and activation of calcineurin a by calpain i in alzheimer disease brain. J Biol Chem. 2005;280(45):37755\u201337762. doi: 10.1074/jbc.M507475200.", "ArticleIdList": ["10.1074/jbc.M507475200", "16150694"]}, {"Citation": "Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM, Landfield PW, Kraner SD. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci. 2005;25(18):4649\u20134658. doi: 10.1523/JNEUROSCI.0365-05.2005.", "ArticleIdList": ["10.1523/JNEUROSCI.0365-05.2005", "PMC1201418", "15872113"]}, {"Citation": "Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid \u03b2-protein disruption of LTP in the hippocampus. J Neurosci Res. 2009;87(8):1729\u20131736. doi: 10.1002/jnr.21998.", "ArticleIdList": ["10.1002/jnr.21998", "19170166"]}, {"Citation": "Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Wang R, et al. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Curr Alzheimer Res. 2009;6(2):118\u201331.", "ArticleIdList": ["19355846"]}, {"Citation": "Tian J, Xu Y, Sheng S, Shi J, Yin J, Wang Y. Influence of GETO extract on myelin sheath structure and myelin basic protein content in the brain with AD model. Alzheimers Dement. 2006;2(3):s601. doi: 10.1016/j.jalz.2006.05.2026.", "ArticleIdList": ["10.1016/j.jalz.2006.05.2026"]}, {"Citation": "Miao Y. Part 5: a randomized, double-blind and parallel control study of GEPT extract in the treatment of amnestic mild cognitive impairment. Beijing: Beijing University of Chinese Medicine; 2008. pp. 95\u2013117."}, {"Citation": "Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A. 1997;94(24):13287\u201392.", "ArticleIdList": ["PMC24301", "9371838"]}, {"Citation": "Dewachter I, Van Dorpe J, Smeijers L, Gilis M, Kuiperi C, Laenen I, Caluwaerts N, Moechars D, Checler F, Vanderstichele H, et al. Aging increased amyloid peptide and caused amyloid plaques in brain of old app/v717i transgenic mice by a different mechanism than mutant presenilin1. J Neurosci. 2000;20(17):6452\u20136458.", "ArticleIdList": ["PMC6772965", "10964951"]}, {"Citation": "Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, et al. Amyloid precursor protein processing and A\u03b242 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A. 1997;94(4):1550\u20131555. doi: 10.1073/pnas.94.4.1550.", "ArticleIdList": ["10.1073/pnas.94.4.1550", "PMC19829", "9037091"]}, {"Citation": "Dewachter I, Revers\u00e9 D, Caluwaerts N, Ris L, Kuip\u00e9ri C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E, et al. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci. 2002;22(9):3445\u20133453.", "ArticleIdList": ["PMC6758348", "11978821"]}, {"Citation": "Tian J, Zhu AH, Zhong J. The effectiveness of GETO in the treatment of mild cognitive impairment in community elderly, A follow-up study on a randomized, single-blind control of GETO pills in treatment of memory disorder in elderly people with MCI in a Beijing community. [Article in Chinese] Zhongguo Zhong Yao Za Zhi. 2003;28(10):987\u2013991.", "ArticleIdList": ["15620194"]}, {"Citation": "Amada N, Aihara K, Ravid R, Horie M. Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease. Neuroreport. 2005;16(16):1809\u20131813. doi: 10.1097/01.wnr.0000185015.44563.5d.", "ArticleIdList": ["10.1097/01.wnr.0000185015.44563.5d", "16237332"]}, {"Citation": "Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in \u03b2-amyloid rat model of Alzheimer\u2019s disease. Biol Psychiatry. 2009;65(11):918\u2013926. doi: 10.1016/j.biopsych.2008.08.021.", "ArticleIdList": ["10.1016/j.biopsych.2008.08.021", "18849021"]}, {"Citation": "Chen Q-S, Wei W-Z, Shimahara T, Xie C-W. Alzheimer amyloid [beta]-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem. 2002;77(3):354\u2013371. doi: 10.1006/nlme.2001.4034.", "ArticleIdList": ["10.1006/nlme.2001.4034", "11991763"]}, {"Citation": "Zhao D, Watson JB, Xie CW. Amyloid \u03b2 prevents activation of calcium/calmodulin-dependent protein kinase ii and ampa receptor phosphorylation during hippocampal long-term potentiation. J Neurophysiol. 2004;92(5):2853\u20132858. doi: 10.1152/jn.00485.2004.", "ArticleIdList": ["10.1152/jn.00485.2004", "15212428"]}, {"Citation": "Simonian NA, Elvhage T, Czernik AJ, Greengard P, Hyman BT. Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons. Brain Res. 1994;657(1\u20132):294\u2013299. doi: 10.1016/0006-8993(94)90979-2.", "ArticleIdList": ["10.1016/0006-8993(94)90979-2", "7820630"]}, {"Citation": "Tian J, Shi J, Zhang X, Wang Y. Herbal therapy: a new pathway for the treatment of Alzheimer's disease. Alzheimers Res Ther. 2010;2(5):30. doi: 10.1186/alzrt54.", "ArticleIdList": ["10.1186/alzrt54", "PMC2983439", "21067555"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "1", "Day": "7"}, {"Year": "2016", "Month": "5", "Day": "25"}, {"Year": "2016", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["27245225", "PMC4888629", "10.1186/s12906-016-1144-7", "10.1186/s12906-016-1144-7"]}}], "PubmedBookArticle": []}